Literature DB >> 4971720

Antiviral activity of carbobenzosy di- and tripeptides on measles virus.

F A Miller, G J Dixon, G Arnett, J R Dice, W A Rightsel, F M Schabel, I W McLean.   

Abstract

A series of simple carbobenzoxy peptides showed high and consistent antiviral chemotherapeutic activity in cell culture. In general, greatest activity was found against the measles-distemper or herpesvirus groups, or both, but various representatives of the series had quantitatively and qualitatively different antiviral activities. Several of the compounds, showing the highest antimeasles activity, were investigated extensively. In human cell culture plaque assays, these compounds were active against measles virus at levels of from 15 to 500 mug/ml. At single doses of about 250 to 500 mg/kg, orally in three animal species, significant serum levels of drugs were detected in virus cell culture assays. The mode of action appeared to be therapeutic, as an effect was seen in cell systems infected for at least 24 hr before treatment.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4971720      PMCID: PMC547690          DOI: 10.1128/am.16.10.1489-1496.1968

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  18 in total

1.  ANTIVIRAL ACTIVITY OF TENUAZONIC ACID.

Authors:  F A MILLER; W A RIGHTSEL; B J SLOAN; J EHRLICH; J C FRENCH; Q R BARTZ; G J DIXON
Journal:  Nature       Date:  1963-12-28       Impact factor: 49.962

2.  Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine.

Authors:  H E KAUFMAN
Journal:  Proc Soc Exp Biol Med       Date:  1962-02

3.  Studies in the biochemistry of micro-organisms. 103. Metabolites of Alternaria tenuis auct; culture filtrate products.

Authors:  T ROSETT; R H SANKHALA; C E STICKINGS; M E TAYLOR; R THOMAS
Journal:  Biochem J       Date:  1957-11       Impact factor: 3.857

4.  Effect of heterocyclic and other thiosemicarbazones on vaccinia infection in the mouse.

Authors:  R L THOMPSON; S A MINTON; J E OFFICER; G H HITCHINGS
Journal:  J Immunol       Date:  1953-03       Impact factor: 5.422

5.  Potential antiviral agents. Carbobenzoxy di- and tripeptides active against measles and herpes viruses.

Authors:  E Nicolaides; H DeWald; M Lipnik; R Westland; J Posler
Journal:  J Med Chem       Date:  1968-01       Impact factor: 7.446

6.  Antiviral activity of gliotoxin.

Authors:  N M Larin; M P Copping; R H Herbst-Laier; B Roberts; R B Wenham
Journal:  Chemotherapy       Date:  1965       Impact factor: 2.544

7.  Searching for antiviral materials from microbial fermentations.

Authors:  J Ehrlich; B J Sloan; F A Miller; H E Machamer
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

8.  Experiences in developing potential antiviral compounds.

Authors:  J R Dice; W A Rightsel; F M Schabel; I W McLean
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

9.  Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis.

Authors:  H KAUFMAN; E L MARTOLA; C DOHLMAN
Journal:  Arch Ophthalmol       Date:  1962-08

10.  Antiviral effect of guanidine.

Authors:  W A RIGHTSEL; J R DICE; R J McALPINE; E A TIMM; I W McLEAN; G J DIXON; F M SCHABEL
Journal:  Science       Date:  1961-08-25       Impact factor: 47.728

View more
  7 in total

1.  Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formation.

Authors:  B J Owens; G M Anantharamaiah; J B Kahlon; R V Srinivas; R W Compans; J P Segrest
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

2.  Effect of certain polypeptides on the biological activities of Measles virus.

Authors:  E Norrby; H Sievertsson
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

3.  Mutations in the Fusion Protein of Measles Virus That Confer Resistance to the Membrane Fusion Inhibitors Carbobenzoxy-d-Phe-l-Phe-Gly and 4-Nitro-2-Phenylacetyl Amino-Benzamide.

Authors:  Michael N Ha; Sébastien Delpeut; Ryan S Noyce; Gary Sisson; Karen M Black; Liang-Tzung Lin; Darius Bilimoria; Richard K Plemper; Gilbert G Privé; Christopher D Richardson
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

4.  Anti-idiotype antibodies that mimic gp86 of human cytomegalovirus inhibit viral fusion but not attachment.

Authors:  S Keay; B Baldwin
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 5.  Measles control--can measles virus inhibitors make a difference?

Authors:  Richard K Plemper; James P Snyder
Journal:  Curr Opin Investig Drugs       Date:  2009-08

Review 6.  Synergizing vaccinations with therapeutics for measles eradication.

Authors:  Richard K Plemper; Anthea L Hammond
Journal:  Expert Opin Drug Discov       Date:  2013-12-05       Impact factor: 6.098

Review 7.  Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds.

Authors:  Katharina S Schmitz; Mona V Lange; Lennert Gommers; Kim Handrejk; Danielle P Porter; Christopher A Alabi; Anne Moscona; Matteo Porotto; Rory D de Vries; Rik L de Swart
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.